Author/Authors :
Xu، نويسنده , , Cheng-Xiong and Jin، نويسنده , , Chien-Hua and Chung، نويسنده , , Youn-Sun and Shin، نويسنده , , Ji-Young and Woo، نويسنده , , Min Ah and Lee، نويسنده , , Kee-Ho and Palmos، نويسنده , , Grace N. and Choi، نويسنده , , Byeong-Dae and Cho، نويسنده , , Myung-Haing، نويسنده ,
Abstract :
Inflammatory mediators are known to play a key role in tumorigenesis, therefore, it is a promising strategy to inhibit the inflammation for cancer prevention and/or treatment. Current study was performed to investigate the effects of chondroitin sulfate (CS) extracted from Styela clava tunic on TNF-α-induced inflammation and to elucidate the mechanism of CS on the regulation of inflammatory factors in JB6 cells. Our results showed that CS inhibited TNF-α-induced NF-κB activation and subsequent vascular cell adhesion molecule 1 and inducible nitric oxide synthase expressions by blocking Akt signals in JB6 cells. Our results suggest that CS may be developed as an effective anti-inflammatory agent in the future.
Keywords :
Chondroitin sulfate , Styela clava tunic , NF-?B , VCAM-1 , Akt , iNOS